5)- Robert Stuver, Zachary D Epstein-Peterson, Steven M Horwitz. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.Haematologica. 2023, 108 (12): 3244-3260
6)- Natasha E Lewis, Ting Zhou, Ahmet Dogan. Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.Haematologica. 2023, 108 (12): 3261-3277
7)- Katja Schoeller, Gabriele Ihorst, Heike Reinhardt, Maximilian Holler, Sophia Scheubeck, Georg Herget, Ralph Wäsch, Monika Engelhardt. Comorbidity indices for prognostic evaluation in multiple myeloma: a comprehensive evaluation of the Revised Myeloma Comorbidity Index and other comorbidity indices with pro- and retrospective applications.Haematologica. 2023, :
9)- Othman Al-Sawaf, Min-Hua Jen, Lisa M Hess, Jiewen Zhang, Benjamin Goebel, John M Pagel, Sarang Abhyankar, Matthew S Davids, Toby A Eyre. Pirtobrutinib venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison.Haematologica. 2023, :
10)- Haley Newman, Suzanne P MacFarland, Garrett M Brodeur, Timothy Olson, Deepa Bhojwani, Jamie Stokke, Alexandra E Kovach, Mary Egan Clark, Minjie Luo, Marilyn Li, Amish Shah, Stephen P Hunger. B-cell acute lymphoblastic leukemia and juvenile xanthogranuloma in a patient with thrombocytopenia and leukemia predisposition syndrome: novel clinical presentation and perspective.Haematologica. 2023, :
11)- Hila Winer, Wenqing Li, Gisele Rodrigues, Tim Gower, Thomas Joshua Meyer, Julie Hixon, Scott K Durum. Mechanism of co-operation of mutant α and mutant in acute lymphoblastic leukemia: role of MYC.Haematologica. 2023, :
12)- Tondre Buck, Monique A Hartley-Brown, Yvonne A Efebera, Carter P Milner, Jeffrey A Zonder, Paul G Richardson, Taylor Salinardi, Megan S Rice. Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States.Haematologica. 2023, :
13)- Sunil Lakhwani, Laura Rosiñol, Noemí Puig, Miguel-Angel Pico-Picos, Laura Medina-González, Joaquín Martínez-López, Bruno Paiva, María-Teresa Cedena, Albert Oriol, Rafael Ríos-Tamayo, María-Jesús Blanchard, Isidro Jarque, Joan Bargay, José-María Moraleda, Estrella Carrillo-Cruz, Anna Sureda, Isabel Krsnik, Esther González, Luis Felipe Casado, Josep M Martí, Cristina Encinas, Felipe De Arriba, Luis Palomera, Antonia Sampol, Yolanda González-Montes, Cristina Motlló, Javier De La Cruz, Rafael Alonso. Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.Haematologica. 2023, :
14)- Naseema Gangat, Naresh Bellam, Kaaren Reichard, Ayalew Tefferi. Emergence of mutation during lenalidomide therapy of myelodysplastic syndrome with del(5q) and its subsequent disappearance following salvage therapy with decitabine.Haematologica. 2023, :
15)- Jonathan L Lühmann, Martin Zimmermann, Winfried Hofmann, Anke K Bergmann, Anja Möricke, Gunnar Cario, Martin Schrappe, Brigitte Schlegelberger, Martin Stanulla, Doris Steinemann. Deciphering the molecular complexity of the IKZF1 genomic profile using Optical Genome Mapping.Haematologica. 2023, :
16)- Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morinea. Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.Haematologica. 2023, :
18)- Hervé Avet-Loiseau, Raphaële Thiébaut-Millot, Xiaotong Li, Jeremy A Ross, Carlos Hader. t(11;14) status is stable between diagnosis and relapse, and concordant between detection methodologies based on fluorescence hybridization and next-generation sequencing in patients with multiple myeloma.Haematologica. 2023, :
20)- Rachel Broadbent, Philip Crosbie, Christopher J Armitage, Ben Taylor, Sean Tenant, Joseph Mercer, John Radford, Kim Linton. Pilot study of lung cancer screening for survivors of Hodgkin lymphoma.Haematologica. 2023, :
24)- Marc S Hoffmann. Routine consolidation of early stage primary bone lymphoma with radiation therapy does not improve outcomes.Haematologica. 2023, :
25)- Silvia Marino, Daniela N Petrusca, Ryan T Bishop, Judith L Anderson, Hayley M Sabol, Cody Ashby, Justin H Layer, Annamaria Cesarano, Utpal P Davé, Fabiana Perna, Jesus Delgado-Calle, John M Chirgwin, G David Roodman. Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma.Haematologica. 2023, :
27)- C Cameron Yin, Wayne Tam, Serena M Walker, Amandeep Kaur, Madhu M Ouseph, Wei Xie, Olga K Weinberg, Peng Li, Zhuang Zuo, Mark J Routbort, Simon Chen, L Jeffrey Medeiros, Tracy I George, Attilio Orazi, Daniel A Arber, Adam Bagg, Robert P Hasserjian, Sa A Wang. mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia.Haematologica. 2023, :
28)- Stien De Coninck, Renate De Smedt, Beatrice Lintermans, Lindy Reunes, Hansen J Kosasih, Alexandra Reekmans, Lauren M Brown, Nadine Van Roy, Bruno Palhais, Juliette Roels, Malaika Van der Linden, Jo Van Dorpe, Panagiotis Ntziachristos, Frederik W Van Delft, Marc R Mansour, Tim Pieters, Tim Lammens, Barbara De Moerloose, Charles E De Bock, Steven Goossens, Pieter Van Vlierberghe. Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.Haematologica. 2023, :
29)- Corrado Girmenia, Fabio Ciceri, Paolo Corradini, Antonio Cuneo, Fortunato D'Ancona, Pellegrino Musto, Antonio Maria Risitano, Maria Teresa Voso, Adriano Venditti, Giovanni Barosi. Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an Italian expert panel.Haematologica. 2023, :
31)- Haley E Ramsey, Agnieszka E Gorska, Brianna N Smith, Andrew J Monteith, Londa Fuller, Maria P Arrate, Michael R Savona. TLR3 agonism augments CD47 inhibition in acute myeloid leukemia.Haematologica. 2023, :
33)- Christopher E Jensen, Allison M Deal, Alexis C Wardell, Hillary M Heiling, Konan E Beke, Daniel R Richardson. Home time among older adults with acute myeloid leukemia by therapy intensity.Haematologica. 2023, :
35)- Willem P J Cox, Nils Evander, Dorette S Van Ingen Schenau, Gawin R Stoll, Nadia Anderson, Lieke De Groot, Kari J T Grünewald, Rico Hagelaar, Miriam Butler, Roland P Kuiper, Laurens T Van der Meer, Frank N Van Leeuwen. Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy.Haematologica. 2023, :
37)- Amanda C Winters, Mohd Minhajuddin, Brett M Stevens, Ajay Major, Grace Bosma, Diana Abbott, Nicholas Miltgen, Ji Yuan, Amy L Treece, Bradford J Siegele, Mark D Ewalt, Jonathan A Gutman, Craig T Jordan, Daniel A Pollyea. Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine.Haematologica. 2023, :
38)- Alessandro Mattè, Enrica Federti, Antonio Recchiuti, Moayed Hamza, Giulia Ferri, Veronica Riccardi, Jacopo Ceolan, Alice Passarini, Filippo Mazzi, Angela Siciliano, Deepak L Bhatt, David Coughlan, John Climax, Elisa Gremese, Carlo Brugnara, Lucia De Franceschi. Epeleuton, a novel synthetic ω-3 fatty acid, reduces the hypoxia/reperfusion stress in a mouse model of sickle cell disease.Haematologica. 2023, :
39)- Anna Falanga, Cinzia Giaccherini. Anticoagulation and thrombocytopenia in cancer: what more can we learn from existing randomized controlled trials.Haematologica. 2023, :
40)- Yuka Uesugi, Daisuke Ikeda, Ami Fukumoto, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Kosei Matsue. Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age.Haematologica. 2023, :
41)- Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Jithma P Abeykoon, Kerstin Wenzl, Zhi-Zhang Yang, Shahrzad Jalali, Jordan E Krull, Esteban Braggio, Michelle K Manske, Aneel Paulus, Craig B Reeder, Sikander Ailawadhi, Asher Chanan-Khan, Prashant Kapoor, Robert A Kyle, Morie A Gertz, Anne J Novak, Stephen M Ansell. MicroRNA and long non-coding RNA analysis in IgM monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.Haematologica. 2023, :
42)- Thibaud Sefiane, Hortense Maynadié, Carmen Escurola Ettingshausen, Vincent Muczynski, Xavier Heiligenstein, Julien Dumont, Olivier D Christophe, Cécile V Denis, Caterina Casari, Peter J Lenting. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc.Haematologica. 2023, :
44)- Bruno A Cardoso, Mafalda Duque, Ana Gírio, Rita Fragoso, Mariana L Oliveira, James R Allen, Leila R Martins, Nádia C Correia, André Bortolini Silveira, Alexandra Veloso, Shunsuke Kimura, Lisa Demoen, Filip Matthijssens, Sima Jeha, Cheng Cheng, Ching-Hon Pui, Ana R Grosso, João L Neto, Sérgio F De Almeida, Pieter Van Vlieberghe, Charles G Mullighan, J Andres Yunes, David M Langenau, Françoise Pflumio, João T Barata. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.Haematologica. 2023, :
45)- Sabine Kayser, Chiara Sartor, Fabio Giglio, Alessandro Bruno, Jonathan Webster, Patrizia Chiusolo, Francesco Saraceni, Selene Guerzoni, Lara Pochintesta, Erika Borlenghi, Giovanni Marconi, Irene Zacheo, Marco Cerrano, Prassede Salutari, Francesco Restuccia, Mariachiara Abbenante, Mark J Levis, Richard F Schlenk, Cristina Papayannidis. Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.Haematologica. 2023, :
47)- Roma V Rajput, Vaani Shah, Ruba N Shalhoub, Kamille West-Mitchell, Nu Ri Cha, Cathy Conry-Cantilena, Susan F Leitman, David J Young, Brian Wells, Georg Aue, Cynthia E Dunbar, Bhavisha A Patel, Richard W Childs, Neal S Young, Colin O Wu, Emma M Groarke, Shelley S Kalsi. Granulocyte transfusions in severe aplastic anemia.Haematologica. 2023, :
48)- Astrid Wintering, Anna Hecht, Julia Meyer, Eric B Wong, Juwita Hübner, Sydney Abelson, Kira Feldman, Vanessa E Kennedy, Cheryl A C Peretz, Deborah L French, Jean Ann Maguire, Chintan Jobaliya, Marta Rojas Vasquez, Sunil Desai, Robin Dulman, Eneida Nemecek, Hilary Haines, Mahmoud Hammad, Alaa El Haddad, Scott C Kogan, Zied Abdullaev, Farid F Chehab, Sarah K Tasian, Catherine C Smith, Mignon L Loh, Elliot Stieglitz. LNK/ as a novel driver in juvenile myelomonocytic leukemia.Haematologica. 2023, :
49)- Andrew P Jallouk, Naishu Kui, Ryan Sun, Jason R Westin, Raphael E Steiner, Ranjit Nair, Loretta J Nastoupil, Luis E Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins, Mansoor Noorani, Kaberi Das, Jared Henderson, Elizabeth J Shpall, Partow Kebriaei, Jeremy Ramdial, Christopher R Flowers, Sattva S Neelapu, Sairah Ahmed, Paolo Strati. Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.Haematologica. 2023, :
50)- Matthew J Maurer, Carla Casulo, Melissa C Larson, Thomas M Habermann, Izidore S Lossos, Yucai Wang, Loretta J Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, Jonathon B Cohen, Brad S Kahl, W Richard Burack, Jean L Koff, Yong Mun, Anthony Masaquel, Mei Wu, Michael C Wei, Ashwini Shewade, Jia Li, James R Cerhan, Brian K Link, Christopher R Flowers. Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.Haematologica. 2023, :